Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Growth Hormone Deficiency Market Growth Performance Trended Historically, And What Lies Ahead?

Over recent years, the market size for growth hormone deficiency has significantly expanded. The market is predicted to increase from $4.06 billion in 2024 to $4.3 billion in 2025, showing a compound annual growth rate (CAGR) of 5.8%. This growth during the historic period is credited to various factors such as a surge in strategic initiatives, an escalation in the occurrence of brain tumors, an amplified demand for hormone therapies, a burgeoning elderly population, and an increase in government healthcare funding.

In the upcoming years, the market for growth hormone deficiency is set to witness robust growth, reaching a market value of$5.38 billion by 2029″ and growing at a compound annual growth rate (CAGR) of 5.7%. This uplift during the forecasted period is mainly attributed to factors such as increasing occurrences of genetic disorders, surge in strategic initiatives, enhanced research and development, a rise in the morbidity of Gh disease, and an increased count of clinical trials. The forecast period will experience predominant trends such as technological evolution, extension of treatment choices, sophistication in diagnostic methods, latest developments in the industry, and strides in biotechnology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21197&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Growth Hormone Deficiency Market?

The proliferating occurrence of genetic disorders is anticipated to fuel the expansion of the growth hormone deficiency market in the future. These disorders pertain to medical anomalies rooted in aberrations or mutations in a person’s DNA, which can either be inherited or occur spontaneously. The increasing occurrence of genetic disorders can be linked to advancements in diagnostic technologies, heightened awareness, escalating maternal age, environmental factors leading to mutations, population growth and augmented survival rates for those affected by these disorders. Growth hormone deficiency treatments are used to manage growth-related complications associated with certain genetic conditions. For example, a report was published by the Department of Health & Social Care (DHSC), a UK-based government department, in December 2022, stating that around 33,000 whole genome equivalents were sequenced in October 2022, with an average diagnostic yield of 32%, which rose to 61% in particular conditions. Therefore, the escalating instances of genetic disorders catalyze the expansion of the growth hormone deficiency market.

Which Primary Segments of the Growth Hormone Deficiency Market Are Driving Growth and Industry Transformations?

The growth hormone deficiencymarket covered in this report is segmented –

1) By Type: Pediatric Growth Hormone Deficiency; Adult Growth Hormone Deficiency

2) By Treatment: Pharmacological Therapy; Recombinant Human Growth Hormone; Human Pituitary Gland Extracts; Surgery

3) By Route Of Administration: Intravenous; Intramuscular; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Pediatric Growth Hormone Deficiency: Idiopathic Growth Hormone Deficiency; Genetic Growth Hormone Deficiency; Acquired Growth Hormone Deficiency

2) By Adult Growth Hormone Deficiency: Primary Growth Hormone Deficiency; Secondary Growth Hormone Deficiency

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21197&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Growth Hormone Deficiency Market?# Market?

North America was the largest region in the growth hormone deficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the growth hormone deficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Growth Hormone Deficiency Market?

Leading businesses in the growth hormone deficiency market are prioritizing the development of novel products, like the unmodified somatropin, for daily treatment of pediatric GHD. Essentially, unmodified somatropin is the same growth hormone used in existing daily pediatric GHD treatments, only that it’s delivered on a weekly basis with Skytrofa. For instance, in September 2023, Denmark’s biopharmaceutical firm, Ascendis Pharma A/S, launched SKYTROFA (lonapegsomatropin) to serve as a once-weekly treatment for pediatric GHD. This revolutionary therapy brings improved convenience, enhanced adherence, and the potential for superior treatment outcomes compared to conventional daily growth hormone therapies. As the only FDA-approved once-weekly treatment for pediatric GHD, it stands as a remarkable breakthrough in the fields of endocrinology and pediatric care.

View the full report here:

https://www.thebusinessresearchcompany.com/report/growth-hormone-deficiency-global-market-report

What Parameters Are Used to Define the Growth Hormone Deficiency Market?

Growth hormone deficiency (GHD) is a medical condition in which the pituitary gland does not produce enough growth hormone (GH). This deficiency leads to stunted growth and development in children and various metabolic issues in adults. Growth hormone deficiency can be congenital (present at birth) or acquired due to injury, tumors, infections, or other medical conditions affecting the pituitary gland.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21197

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model